Amylin receptor antagonists capable of binding to the amylin receptor andinhibiting activity ofamylin or amyloid-beta protein are provided. The amylin receptor antagonistscan beadministered in the form of pharmaceutical compositions or the like. Methodsfor preparing andusing the amylin receptor antagonists for treating, preventing, orameliorating Alzheimer'sdisease are also provided.